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The relationship of outer membrane protein II of Neisseria 
cronorroheae to colony opacity and serum killing 
(86pp.) 
Outer membrane protein II (PII) variants in seven 
gonococcal strains were isolated with the indication of 
colony opacity and sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. High frequency switching in PII expression 
of organisms was indicated by variation in colony opacity. 
These extensive changes of PII expression possibly help 
organisms evade host immune response and increase the 
ability of bacteria to adjust to different internal 
environments. Gonococci forming opaque colonies posses a 
group of PIIs that are lacking in organisms which form the 
transparent colonies. In experimental strain FA899, the 
opaque phenotype colonies were observed despite the absence 
of PIIs in those colonies, which implies the involvement of 
other surface structures the colony opacity. 
The serum sensitivity of opacity variants was examined 
with microassay. The opaque variants tend to be more 
resistant to normal human serum (NHS) than isogeneic 
transparent colonies. These results suggest that expression 
of PIIs enhance bacterial survival in the host. 
Unlike other serum assays, serum killing in this 
microassay is likely mediated by a group of heat stable low-
molecular-weight cationic proteins other than complement. 
Director: Dr. Ralph C. Judd 
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Neisseria gonorrhoea (GC), the pathogenic agent of 
gonorrhea, is one of the most common sexually transmitted 
diseases in humans (7) . It causes diseases ranging from 
uncomplicated genital infections to complicated infections 
including pelvic inflammatory disease and disseminated 
gonococcal infection (DGI) (7, 50). Human mucosae, such as 
the urethra, rectum, pharynx conjunctiva and endocervix (7) 
are most commonly infected. GC infects men, women, infants, 
even the unborn. In recent years, antibiotic-resistant 
strains of GC have appeared, causing an increasing in cases 
not responsive to treatments of antibiotics (15). GC 
infects individuals worldwide at any time of the year, not 
just in seasonal epidemics or in localized areas. Despite 
considerable efforts to control its infection, gonococcal 
disease still remains a common public health problem. 
Approximately 375 cases per 100,000 population were reported 
in the United States in 1987 (11). 
Structural variation of surface components is one 
effective way used by many pathogens to evade the host 
immune response. GC uses this method to evade host immune 
responses. The antigenic determinants on the membrane 
surface of GC, such as outer membrane proteins (OMPs) and 
lipopolysaccharide (LPS), appear to play a major role in 
pathogenesis. Those surface factors can change rapidly, 
making it possible for this gram-negative diplococcus to 
evade the host immune defense, conferring significant 
advantages in bacteria survival, and allowing GC to adapt to 
changes in the host environment. Antigenic variation (12, 
41, 77, 78) and natural transformation (73) are thought to 
be responsible for those extensive variations. The 
variability of outer membrane (OM) structures has 
contributed to our general failure to develop a vaccine and 
probably account for multiple and recurrent gonococcal 
infections (95). 
Pili are hairlike structures present on surface of GC. 
They consist of identical multiple pilin subunits. Pili 
range in molecular mass from about 19,000 dalton 19K to 25K 
(64, 71). Pili are one of the predominant variable factors 
of the OM and play an extremely important role in the GC 
pathogenesis (83). 
Specific gonococcal colony forms were correlated with 
GC virulence by Kellogg, et al (42, 43, 83). Four colony 
types are observed Tl, T2, T3, T4. Each colony type was 
morphologically different (8). Type 1 and type 2 (virulent) 
produced typical acute venereal infection whereas type 3 and 
type 4 (avirulent) caused only mild, transient symptoms 
without establishment of infection (42, 43). Pili have been 
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found only on the cells of type 1 and 2 and are absent from 
type 3 and 4 (3, 82). Data by J. Swanson and others (9, 24, 
60, 83) suggested that piliated small colonies of GC are the 
invasive form of the species. This suggests a correlation 
between the virulence of GC and the presence of pili. 
Chromosomal rearrangements, such as deletions of pilus genes 
and intragenic recombination cause phase and antigenic 
variation. This enhances bacterial survival and virulence 
(18, 22, 55, 74). It has been shown that pili are involved 
in the first of a two-stage attachment process of GC 
infection. They help overcome the electrostatic barrier 
which exists between the negative charged surfaces of 
gonococcus and the host cell (24). Purified gonococcal pili 
attach to the cervical-vaginal and buccal epithelial cells 
(normal host cells) much better than they attach to the 
erythrocytes, leukocytes or fibroblast (59). This finding 
suggests that a specific relationship exists between GC and 
their host cells. Receptors on the host cells can 
specifically bind to the receptor-binding domain of the 
pilus molecule has been found. This site consists of 80 
amino acid residues from 31 to 111 of pilus molecule (71). 
Antibodies against pili specifically block this binding, 
dramatically reducing the attachment to the host cells. 
This characteristic has made pili a potential candidate for 
a vaccine. However, indicative efforts to develop a pilus 
vaccines have not been successful, suggesting that the 
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extensive changes of pilus molecules caused by the phase and 
antigenic variation (76) may make pili unsuitable for a 
vaccine. 
Outer membrane protein I (PI), which is present in all 
gonococci examined, is the major OMP of GC with a molecular 
mass varying from 34K to 38K (1, 36). It varies in subunit 
molecular mass among strains but is identical for all 
intrastrain variants (1) and accounts for approximately 60% 
of the protein in the OM (31). Two major groups of Pis, PIA 
(34-36KDa) and PIB (36-38KDa), have been recognized in the 
OM of GC and can be further subdivided by using monoclonal 
antibodies (MAbs) (44). PIA and PIB appear to be orientated 
differently in the OM. The PIAs have their N-terminal 15-20 
amino acids exposed on the surface (1), while PIBs have both 
termini buried in the membrane, with a central region 
exposed on the surface (1, 38, 40). These two subclasses 
are structurally and electrophoretically distinct. Certain 
biological characteristics have been correlated with the PI 
types that the organisms bear. Pis affect the inhibition of 
bacterial growth by proteolytic enzymes, and influence 
sensitivity to serum killing (28). The strains isolated 
from the blood stream of patients with DGI are usually 
resistant to the bactericidal action of normal human serum 
(NHS) and tend to belong to the PIA group. Strains isolated 
from uncomplicated genitourinary disease tend to belong to 
group PIB and are often serum sensitive (39, 70). Because 
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of the distinctive exposure of PI subclass molecules in the 
OM, PIAs are resistant to in situ cleavage by a-
chymotrypsin, trypsin and proteinase K, while PIBs are much 
more susceptible to those enzymes. The molecular mass of PI 
has been correlated with serum sensitivity, with strains 
bearing PI of the higher molecular mass more sensitive to 
NHS killing (9, 29). Pis also serve as porins which form 
hydrophilic channels across OM and are the major 
determinants for serotypic specificity in the membrane (31). 
Although the PIA in GC strains WS3 and WS5 are identical, a 
slight alteration of exposure of PIAs present in these two 
strains was correlated with altered LPS and /or H.8 antigen 
structure found in those two strains. Many more alterations 
of exposure of PIBs were found in strains WS2 and WS4 which 
also correlated with the variations in LPS and/or H.8 
antigen structure (41). It is possible that PI with LPS and 
/or H.8 antigen form a complex on the OM. Since PI appears 
to be invariant within a strain, this implies the organism 
may have developed a mechanism to protect this molecule from 
the immunological attack of the host by changing the other 
OM components (41). 
Outer membrane Proteins II (PII), a group of 
heat-modifiable proteins on the surface of gonococci, may be 
important virulence associated OMP. They range in apparent 
molecular mass from 24KDa to 30KDa and are highly exposed on 
the surface of the bacteria (6, 25, 26, 65, 86). Since they 
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correlate with difference in colony opacity, they are also 
called opacity-associated proteins (25, 31, 45, 88, 90, 96). 
Although PII molecules show a high degree of sequence 
conservation in their primary structure, they are function­
ally, serologically, and structurally distinguishable (89). 
The difference has been seen in primary structure, antigenic 
determinants, and migration in SDS-PAGE gels (14, 27, 37, 
86, 88). A single organism can express from zero to four 
PII species with different combinations, with a single 
strain (MSll) able to produce as many as 11 electrophoretic-
ally distinct PII variants (2, 4, 14, 72, 88). 
Protein lis are not structurally related to any of the 
other OMPs (37). The members of the PII family share about 
60% homology when compared by peptide mapping of 
a-chymotrypsin digests of purified proteins. The other 40% 
of the peptide are unique to each PII and represent the 
portion of the molecule which is exposed on the surface of 
bacteria (27, 37, 86). Antisera from purified PIIs of three 
strains react with PIIs of all heterologous strains, but the 
strongest reactions are with homologous PIIs (54, 72). 
However MAbs are very specific for each PII, showing little 
cross reactivity with other PIIs (4). Confirming PII 
peptide mapping, the DNA sequence of two cloned PII genes 
shows that they are very similar in large regions (80% 
homology) with difference only in two short hypervariable 
(HV) regions and a semivariable region which encodes the 
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N-terminal amino acids (77). Those two short hypervariable 
regions are responsible for most of the differences of PIIs 
(12). The restriction fragments containing only the HV 
regions cloned into an expression vector demonstrated that 
the epitopes recognized by specific PIIs monoclonal 
antibodies were completely encoded by either HV, or HV2 
(13). 
PIIs are subject to extensive phase and antigenic 
variation (76, 77, 78). The genes are switched on and off 
nonrandomly at very high frequency. The average rate of 
change is about 2xl0~3 per cell per generation (48). This 
is too high to be explained by random mutation and 
reversion. This rate is not affected by the change in 
growth temperature, pH, amount of oxygen present, or state 
of piliation (48), but some substances such as pyruvate may 
induce the phenotypic change of GC (56, 57). 
The expression of PIIs is controlled by a group of 
genes spread over throughout the gonococcal genome (77). At 
least nine expression loci (opa E) are involved in 
production of a large number of serologically distinct 
phenotypic variants. No correlation was found between the 
number of proteins produced and the number of opa loci; each 
locus may not be active in the production of a protein (93). 
The DNA sequence rearrangement that controls Salmonella 
phase variation may also contribute the rapid reverse 
phenotype changes in gonococci (12, 96). The recombination 
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among PII genes generates new coding sequences and 
contributes to the increase of structural variability in the 
PII family (12). Also, the genetic transformation of PII 
genes from a donor into a recipient was detected by MAbs 
(73). The DNA sequence rearrangement, PII genes 
recombination, and genetic transformations are thought to be 
responsible for the antigenic variation. Regulation of PII 
phase variation commonly occurs at the translation level 
(73, 77). A striking finding has been made when analyzing 
the opa-genes. All the opa-related genes appear to have a 
common 5'-coding sequence which includes a repetitive 
sequence, termed the coding repeat (CR). CR composed of 
pentameric CTCTT units. The number of the repeating units 
that code for the hydrophobic part of a leader or signal 
peptide is variable while all expression loci in a single 
cell are constitutively transcribed. However, the 
production of functional opacity proteins can only occur if 
the translational start codon ATG is in frame. The reading 
frame is controlled by the repeat sequence at translational 
level. Such repeat sequences can be spontaneously added or 
lost maneuvering the PII structural genes into or out of 
frame with ATG initiation codon so that either full-sized 
PII protein or a truncated protein is synthesized (77, 78). 
CR variation is thought to be the basic mechanism involved 
in phase and antigenic variation of PIIs expression (53, 
58). Insertion and deletion of CTCTT repeats probably 
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involves slipped-strand mispairing of the DNA which occur 
during DNA replication or non-replication duplex. Changes 
could also result from unequal crossing-over among the 
signal peptide coding regions of different PII genes in the 
chromosome (53). Phenotypic changes of GC associated with 
variable PII expression occur not only in vitro but also in 
vivo during the course of gonococcal infection (60, 72, 89). 
Cultures from male urethrae tend to contain more opaque or 
(Pll-bearing) colonies than those from female cervices (30). 
It was also found that cultures isolated at different 
anatomical locations have different predominant PII 
phenotypes. Even the cultures taken from the same location 
at different time intervals show different PII phenotypes. 
The phenotype of cultures taken from cervices depends on the 
stage of the menstrual cycle and whether or not the 
contraceptives have been used (30, 85, 90). 
The function of PIIs has not been definitively 
determined. But this group of proteins has been 
characterized by: 
1. Heat-modifiablity: It is a very specific characteristic 
of PIIs and has been used to recognize PII bands on an SDS-
PAGE gel. After heat-modification (solubilized sample at 
100°C), PIIs migrate more slowly in SDS-PAGE gel. The PII 
bands, appeared on the SDS-PAGE gel with the cells 
solubilized at 37°C disappeared when solubilized the cells 
at 100°C, and the new bands with larger molecular mass 
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appear instead (88). 
2. Relationship to colony opacity: In general the colonies 
are transparent when the organism lacks expression of PIIs. 
Different PII types have been correlated with distinctive 
degrees of colony opacities (88), however some PIIs do not 
show a discernible increase in colony opacity when present 
alone or in combination with other opacity-associated PIIs 
(30, 84, 85). Colony opacity is also thought to be a very 
reliable criteria used to select the different PII variants. 
3. Virulence association: Mucosal isolates tend to have 
PIIs, while isolates from the blood always lack PIIs (46). 
The organisms expressing PIIs have been shown to be less 
virulent in the chicken embryo-model than those lacking PIIs 
( 6 6 ) .  
4. Sensitivity to protease: PIIs are more sensitive to 
hydrolysis by trypsin than the major outer membrane protein 
(PI) of GC (85). It is of interest that the other outer 
membrane proteins in organisms containing PIIs are more 
sensitive to hydrolysis by trypsin than in those organisms 
which do not contain PIIs (5, 30, 84, 85). 
5. Interaction with neutrophils: Most but not all PIIs can 
stimulate neutrophil respiratory burst and phagocytic 
killing. This ability of protein II bearing gonococci is 
mediated by lectin-like components, including a number of 
simple monosaccharides and sugars (62). Pll-lacking GC 
adhered poorly to neutrophils and the GC were not killed at 
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the same rate as Pll-bearing bacteria (16). 
6. Ability to adhere to diverse types of eucaryotic cells: 
PIIs appear to be important in attachment to the diverse 
eucaryotic cells (16, 45, 65). Colonies possessing PIIs 
tend to clump together while colonies not expressing PIIs 
are less adherent to each other (84). MAbs against PII can 
specifically inhibit the attachment of GC to Hela cells (81) 
helping to prevent infection. The interaction of PII with 
host cell surface components has been studied, showing that 
the predominant binding interactions were with proteins 
rather than carbohydrates. The chemical nature of 
interaction is very complex, involving more than purely 
ionic or hydrophobic forces (3). 
7. Change serum resistance: increased sensitivity to killing 
by normal human serum (NHS) has been shown to correlate with 
PII expression (29), but P. R. Lambeden reported the 
opposite results in his experiments in 1979 (46) . 
It is likely that expression of distinct PIIs in 
variants of GC helps them to evade host responses and to 
survive in different micro-environments. 
Outer membrane PHI, a surface exposed protein which is 
present in all GC strains examined (87). It appears to be 
30KDa to 31KDa daltons and to be biochemically and 
immunologically identical in all strains studied (36, 63). 
In marked contrast to the PI and PIIs, no phase or antigenic 
variation has been noted in PHI. So it is likely that PHI 
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is a cross reactive antigen among all GC, but the antisera 
raised against whole JS1 could not immunoprecipitate PHI of 
JS3. This suggests that PHI is either non-immunogenic or 
non-antigenic in intact organisms (36). PIII is only 
present in outer membranes of fresh isolates and is labelled 
with 125I in outer membrane preparations (26) . The functions 
of PHI are not known, however it is possible that this 
protein serves as a target for blocking antibodies found in 
NHS which block the bactericidal activity of NHS (35, 63). 
Protein III is closely associated with PI and may, 
therefore, contribute to the function of the OM pore formed 
by PI (63). 
H.8 antigen, another antigenic determinant on the outer 
membrane of GC, is a lipoprotein with an unusual amino acid 
sequence (20, 79). It appears to be invariable in 
intrastrain variants (80) and it stains poorly with the 
common stains used for visualizing the proteins on SDS-PAGE 
(Silver and Coomassie Brilliant Blue) (10). These staining 
characteristics can be explained by its unusual amino acid 
sequence, rich in alanine and proline, and the lack of 
aromatic and sulfur-containing amino acids. It is protease-
sensitive, heat-modifiable but is not modified by 2-ME (10). 
The functions of this antigen are not clear. It is only 
detected in pathogenic gonococci and meningococci, but it is 
not found in nonpathogenic Neisseria species. This suggests 
that H.8 antigen may be an important virulence factor of 
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gonococcus (10). 
Lipopolysaccharide (LPS) is an antigenic determinant 
found on the surface of GC and another variable factor on 
the OM (19, 51, 75). It appears to have a critical role in 
determining the sensitivity of gonococcus to NHS (21, 75). 
LPS interacts with membrane proteins and appears to 
influence the exposure of PI on the surface of bacteria 
(41). LPS varies in size, structure, and antigenic 
expression both among strains and within strains. The 
chemical composition and structure of GC LPS are largely 
unknown. Three antigenic determinants have been indicated 
on the LPS molecules of GC: the common, variable and 
serotype antigens (51). The common antigen is present on 
all LPS molecules of GC, whereas the variable antigen may or 
may not be present. At least six serotype antigens are 
found on the LPS of GC. Unlike the LPS in other 
gram-negative bacteria, the LPS of GC has very short or no 
"O"-antigenic side chains (51). 
Resistance to killing by NHS is a common phenomenon of 
gram-negative microorganisms (91, 94) and an important 
determinant of virulence in at least some infections due to 
gram-negative bacteria; although much of the literature does 
tend to show a relationship between sensitivities to serum 
and the ability to cause infection. The precise role and 
relative importance of serum resistance at any stage of the 
infection process is not clear at present. The majority of 
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GC strains isolated from patients with DGI are resistant to 
serum-killing, whereas strains isolated from mucosal sides 
are often sensitive to serum-killing (67). Two distinct 
forms of serum resistance have been observed (49). The 
first (stable) form of serum resistance persists during 
prolonged repeat passages on agar and was lost only when 
colony morphology changed. The second (acquired) form of 
serum resistance was discovered by selecting survivors in 
serum containing media. The acquired form of resistance was 
rapidly lost during repeated passage on agar without any 
changes in colony type. The factor in the serum which 
appeared to be stable to heating at 56°c was thought to be 
responsible for the acquired form of resistance. After 
dialysis, resistance-enhancing activity was found in the low 
molecular weight (12KDa to 14KDa) diffusate of serum. This 
resistance was greatly reduced by prolonged or low 
temperature (8°C) incubation and enhanced by lowered PH 
(94). 
Bactericidal activity of NHS against gram-negative 
microorganisms involves both antibody and complement, but 
surprisingly little is known about the target antigens and 
how the serum resistant strains evade the host defense 
system (93) . Antigonococcal AB in NHS result, ixonv tYve 
presence of commensal gram-negative bacteria or with 
nonpathogenic Neisseria found in the respiratory tract. 
This is supported by the observation that AB can be removed 
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by absorption with some gram-negative organisms (19). The 
result of AB binding to GC is the activation of complement 
cascade. The resultant C5b-9 membrane attack complex (MAC) 
causes the lysis of cells. Alternative activation pathways 
may also be involved. C4 is essential for alternative 
pathway activation. However, the C4-deficient serum can 
still activate complement, but at a slower rate (68). No 
difference exists in the amount of complement activated nor 
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in the MAC formation between the serum sensitive and 
resistant strains (23, 32, 33). However, the MAC fails to 
insert properly into the membrane of serum-resistent strains 
(17). Joiner, et al (34), demonstrated that C5b-9 forms 
high molecular weight complexes with outer membrane 
constituents of the serum-resistant strains, but not with 
serum-sensitive strains. These high molecular weight 
complexes may be responsible for the failure of the MAC to 
insert into the OM properly in resistant strains. Recent 
research has shown that blocking ABs for some surface 
components, especially PHI (63), which protect those 
surface components from attack by the specific bactericidal 
antibodies, may also contribute to the resistance of killing 
by NHS. 
LPS is the main target antigen for ABs in the NHS (19, 
68, 69, 75). For many years, researchers have tried to 
establish the relationship between LPS and sensitivity to 
killing by NHS. Several characteristics of LPS , such as the 
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molecular weight variation and the difference in sugar 
composition, have been associated with serum-sensitivity, 
but no consistent correlation with a single variant has been 
found (68). The 3.6KDa LPS component is commonly expressed 
by serum-resistant strains in varying amounts. The antibody 
specific for this 3.6KDa LPS is not found in the NHS, but 
when this antibody is added to NHS, it will initiate the 
lysis of bacteria mediated by human complements (9). This 
might mean 3.6 KDa LPS is although immunogenic, but it is 
not antigenic. 
PIAs are associated with serum-resistance (39). The 
higher the molecular masses of the PIAs are, the more 
sensitive the bacteria are to the killing by NHS. It is 
interesting that among bacteria having the same PI, 
transparent colonies (organisms bearing no PII) appear to be 
more resistant to serum killing than opaque bacteria. 
Bacteria which survive in the presence of NHS tend to shut 
off PII expression and revert to transparent colonies (29). 
A genetic locus (sac-1) which has an effect on the level of 
serum resistance of GC was identified by Cannon, et al (9). 
This locus is closely linked to, but not identical with, a 
second locus (nmp-2) that affects PI. 
Many surface components of GC are involved in the serum 
sensitivity. The contributions of each of these components 
to the total serum sensitivity is still unclear. 
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Overall Objective: 
As mentioned above, the PIIs are important OM proteins 
of GC They are associated with variation in virulence 
properties such as susceptibility to the bactericidal 
activity of NHS, attachment to diverse eucaryotic cells, 
susceptibility to phagocytosis and protease. Therefore, 
they may play an important role in GC infections. 
This study proposes to study seven well characterized 
strains of GC (WS1, WS2, WS3, WS4, WS5, FA102, FA899) to 
elucidate the pattern of their PII expression. I will try 
to determine which PIIs are expressed and how many PIIs are 
produced in each strain. Since some strains (FA102 and 
FA899) are parent strains of others, it will be of interest 
to find out the relationship of PII expression in the 
parental and their derivative strains. I will then attempt 
to determine the relationship of PII expression to 
resistance and sensitivity to killing by NHS in WS1, WS2, 
WS3, WS4, WS5, FA102, and FA899. Results should help us to 
understand the role that PIIs play in serum resistance and 
propagation of GC infection in general. 
Research Goal 
1. Determination of PII types expressed in a set of seven 
transformant strains of N. gonorrhoea. 
2. Comparison of the expression of PII of a parent stain 
with that of its derivative strains of N. gonorrhoea. 
17 
3. Correlation of PII expression with PI and LPS. 
4. Examination of the possible relationship between PII 
expression and sensitivity to bactericidal action of 
NHS in strains WS1, WS2, WS3, WS4, WS5, FA102 and FA899. 
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CHAPTER II 
MATERIALS AND METHODS 
Bacteria: Seven strains of N. gonorrhoea. which have been 
well characterized in our lab, were used in the 
experiments. Table 1 details the origins and serum killing 
phenotypes of these strains (Results from Robin K. Pettit's 
experiments in our lab). The reason that I chose those 
particular seven strains, is that they have been w^ll 
characterized in our lab and they are all genetically inter­
related (transformants). FA102 and FA899 are general parent 
strains of five other strains WS1, WS2, WS3, WS4, WS5. Four 
out of seven (FA102, WS1, WS3, WS5) have PIA and the other 
three (FA899, WS2, WS4) have PIB. The pictures of their PII 
expression will give us clear information about genetic 
events that happened when different PIIs were expressed. 
These characterized strains could be used to establish the 
role of PII molecules in a variety of cellular functions. 
PI is an important factor that affects the sensitivity 
to serum killing, but it is not the only factor. The other 
surface components such as LPS and PIIs also change the 
serum sensitivity. Table II (on page 21) shows protein I 
type, migration of LPS, and H.8 antigen of these seven 
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strains (41). 
It is interesting to compare the variants which have 
the same PII expression with different PI backgrounds, and 
also the variants having the same PI background, but with 
different 
PIIs expressed. 
The strains were grown on the modified clear typing 
agar as previously described (84) at 37°C in 5% C02 
atmosphere. Single colonies were selected and passed each 
day to ensure that pure cultures of each colony type were 
used. Colonies were chosen on the basis of color and 
opacity characterized by the criteria of J. Swanson (88) and 
verified by sodium dodecyl-sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). 
Electrophoresis: Colonies with various opacities which 
reflect Pll-types, were harvested from solid medium into 
1.5ml of complete Dulbecco phosphate buffered saline pH 7.4 
(dPBS) and the absorbance was read with Coleman Junior II 
spectrophotometer. The suspensions were adjusted to optical 
density (OD) 0.68 at 600nm, and centrifuged at 10,000 R.P.M 
for 1 min. The pellets were solubilized in SDS solubilizing 
solution containing 4% of 
2-mercaptoethanol at 37°C and 100°C as previously described 
(12). The whole cell lysates were separated by 
electrophoresis on an SDS-PAGE (12.5% acrylamide) for about 
2 h at 10W constant power. The gels were then fixed in 7% 
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acetic acid -25% isopropyl alcohol (IPOH) overnight and 
stained with 0.2% Coomassie Brilliant Blue (CBB). The 
molecular mass of each PI and PII was determined on the gel 
by comparison with molecular weight markers (Bio-Rad low MW 
marker standards kit). In addition, silver staining was 
performed on 15% acrylamide with double cross linkage (1:16) 
SDS gel, as described Tsai and Frash (92) to show the LPS 
patterns ofdifferent variants in each strain. 
Microscopy: A stereo microscope (Stereo Zoom 7 Bausch & 
Lomb, Rockester NY) equipped with a substage reflector 
having both a diffusing surface and a plane polished mirror 
was used for discerning the color and opacity characteris­
tics of gonococcal colonies. 
Serum: Pooled normal human serum of healthy donors having 
no history of infection with GC (the generous gift from Dr. 
William M. Shafer, Department of microbiology and 
immunology, School of Medicine, Atlanta, GA. 30322) were 
stored in 1ml portions in micro-centrifuge tubes at -70°C 
until use. The serum was thawed at room temperature 
immediately before use and used only once. 
Isolation of PII variants: Colonies showing varying opacity 
were restreaked and grown for 18-2Oh on clear typing medium. 
Colonies from those plates were harvested, solubilized, and 
separated by 12.5% of SDS-PAGE gel and stained for 
identification of PII expression. Bacteria from the same 
plate were used for the serum killing assays. 
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TABLE I: 
Strains of Neisseria gonorrhoea used, origins and serum 
killing phenotypes 
STRAIN SOURCE PERCENT KILLING SERUM-KILLING 
± S.E.M.2 PHENOTYPE3 
FA899 W. shafer1:FA889XFA19 2.4±8.1 SR 
FA102 " :FA48XFA19 12.4±6.8 SR 
WS1 " :spontaneous pyocinR 102.4±0.0 SS 
mutant of FA102 
WS2 " :FA899XWS1 98.4±0.0 SS 
WS3 " :FA899xWSl 102.4±0.0 SS 
WS4 " :WS2xFA102 42.9±7.5 SR 
WS5 " :WS2xFA102 43.9±6.1 SR 
1 - Dr. William M. Shafer, Department of Microbiology and 
Immunology, Emory University School of Medicine, Atlanta, GA 
30322,and The Veterans Administration Medical Center, 
Decatur, GA 30033 
2 _ Percent decrease in cfu with 25% pooled normal human 
serum (PNHS)± standard error of the mean (S.E.M.) 
3 - Serum resistant (SR)- >50% survival in 25% PNHS; Serum 
sensitive (SS)- <50% survival in 25% PNHS 
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Bactericidal Hicroassay: The microbactericidal assay, a 
method to determine serum bactericidal activity, performed 
as described by Schneider and Griffiss 1982 (47, 67, 94), 
was used in this experiment to determine the serum 
sensitivity of all the PII variants in seven strains of GC. 
As mentioned before, the cells tended to adhere together 
when they express PII. We faced the problem of the cells 
sticking together to form the colonies on the plates while 
performing the dilution plate assay (a common and reliable 
method used to determine serum sensitivity of bacteria by 
many scientists). The accuracy of results was largely 
affected by this characteristic of Pll-bearing cells. We 
tried several methods in order to solve this problem: I. To 
remove GC aggregates, the suspensions were homogenized by 
vortex mixing and then centrifuged at 500g for 10 min before 
performing the dilution plate assay which was suggested by 
P.R. Lambeden (46). II. The sonicator was used to separate 
the cells. None of these methods worked very well. The 
first method did not separate the cells any better; the 
irregular shaped colonies which formed from more than one 
cell still appeared on the plates. Under the second method, 
if the suspensions were sonicated less the 5 min it did not 
affect the cell homogenate, but more than 5 minutes would 
largely reduce the cell counts, indicating some cells were 
killed in the process. The bactericidal microassay avoids 
the requirement for accurate counting of the colonies, so 
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TABLE II: 
Protein I type, migration of LPS and H.8 antigen of seven 
strains of GC used 
Strain P.I type LPS migration H.8 migration 
FA899 P.IB9 Slow Intermediate 
FA102 P.IA1 Intermediate Intermediate 
WS1 P.IA1 Fast Fast 
WS2 P.IB9 Fast Fast 
WS3 P.IA1 Fast Fast 
WS4 P.IB9 Slow Slow 
WS5 P.IA1 Slow Slow 
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the results were not affected by the adhering characteristic 
of Pll-expressing cells. In this particular experiment, the 
microassay method appears to be more appropriate than the 
other serum bactericidal assay. Also in our lab, Robin 
Pettit compared the dilution plate assay with the 
microassay. Although little correlation has been found 
between these two assays in her experiments, it has been 
shown that the microassay was still a rapid, repeatable and 
reliable method to determine serum bactericidal activity. 
So we used the serum microassay instead of the dilution 
plates assay for serum bactericidal experiments. 
Eighteen hour cultures of bacteria were suspended in 
the clear typing medium lacking agar (76) and the organisms 
were dispersed by vortexing. The suspensions were adjusted 
to 0.30 optical density at 600 (about 3x10® CFU/ml) with 
Coleman Junior II Spectrophotometer. Serum (0.2 ml) was 
diluted in serial 2-fold dilutions (1:4 to 1:4096) with 
clear typing broth in a sterile, flat-bottomed 24 well 
tissue culture micro-titer plate (Corning Glass Works, 
Corninig, NY). The serial two-fold dilutions of 0.2 ml of 
serum in clear typing broth were also made in sterile 24 
well tissue culture microtiter plates (Corning Glass Works, 
Corning, NY). An equal volume of clear typing broth 
containing about 3xl04 cfu/ml was added to each well. The 
plates were incubated at 37°C for 45 min before overlaid 
each well with 0.3 ml of molten agar equilibrated to 52°C. 
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All the test plates were then incubated at 37°C for about 20 
hours. The bactericidal titers were determined by the last 
serum dilution which killed 100% of the bacteria. The 
controls included incubating the bacteria in both clear 





A single transparent (non-opaque) colony of each strain 
lacking any detectable PII was selected and passed. During 
the passages, we observed that the majority of colonies in 
the culture had the characteristics of their parental 
colonies which were transparent and did not express any kind 
of PIIs (0") . However, there were occasional variants 
showing different colony opacity in the culture. Usually 
the colonies of those variants displayed from an 
intermediate (o+) degree to a marked (o**) degree of opacity. 
These desired colonies with different opacity were selected 
and cultured. As previously stated, the colony opacities 
were often associated with different PII expression. A 
sample containing a mixture of opacity variants could 
contain organisms expressing different PII species. Also, 
organisms were capable of changing their colony opacity 
which generally indicated a change in the PII expression 
during the passages. Of course, the results from a 
heterogeneous PII population mixture culture would be 
difficult to interpret, as they possibly were contributed by 
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any PII variants or all of them within the mixed culture. 
For these reasons, the colonies of different variants were 
examined very carefully with a dissecting microscope, using 
the criteria of J. Swanson (88) to ensure the right colonies 
were picked and passed. 
Obtaining pure cultures of opacity (PII) variants in 
each strain was very important and was considered to be the 
first step of our experiments. 
PII Variants in Seven Strains of GC: 
PII variants from seven transformant strains, FA102 
FA899 WS1 WS2 WS3 WS4 WS5, were selected for this study. 
The pure cultures of all the opacity variants in each strain 
were harvested by scraping plates and solubilized in the 
solubilizing solution with 2-mercaptoethanol at 60°C and 100 
°C. SDS-PAGE was performed with all the solubilized samples 
to identify the PIIs expressed by each variant. The PII 
variants were maintained by selective passage on clear 
typing medium each day. In addition, more PII variants were 
continuously selected over a six month time period. 
The molecular masses of Pis and PIIs of each strain 
were determined by separating whole cell (WC) lysates in 
12.5% or 15% acrylamide gels and comparing the migration to 
standard molecular weight markers. Whole cell lysates of 
each strain were then arranged on the 12.5% and 15% SDS gel 
based on the increasing apparent molecular mass of the PIIs 
when whole cells were solubilized at 37°C. Gels were 
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stained with 0.2% of CBB or silver, as described by Tsai and 
Frash (92) . 
The CBB stained 12.5% gel of the whole cell lysates of 
transparent colonies revealed that Pis in strains WS1, WS3, 
WS5, and FA102 migrated identically, having a molecular mass 
of about 36 Kd. The Pis in strains WS2, WS4, and FA899 also 
showed the identical migrations on the 12.5% CBB stained SDS 
gel with an the apparent molecular mass of around 37 Kd 
(Fig. 1). 
The majority of the population in our stock cultures 
were transparent and, therefore,did not express PIIs. 
However, the opaque colonies occasionally arose from the 
transparent parents. Usually one or two distinct opacity 
variants were regularly selected among the progeny of 
transparent PII" colonies of each strain. The differences 
in colony opacities were due to the different PII expressed 
in these colonies, as illustrated in table III. 
In the seven experimental strains, the transparent 
colony phenotype usually correlated with a PII" variant. 
The only exception was in the strain FA899, where no truly 
transparent phenotype colonies could be found within the 
experimental period of more than a half year. Therefore, a 
PII" variant in FA899 was selected from the colonies which 
had intermediate opacity (0+) . In all other strains, the 
intermediate (0+) colony opacity was associated with a 
single PII that had a molecular mass of about 25.2 Kd. But 
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the variant expressing the 25.2 Kd PII protein in strain 
FA899 appeared to have marked (0++) colony opacity. The 
rest of the PIIs selected from seven transformant strains 
imparted marked opacity (0++) to the colonies. 
Unfortunately, it was not possible to predict the particular 
PII types based on the 0** phenotypes. Therefore, several 
0++ colonies were selected, solubilized, and separated on 
the SDS-PAGE gel in order to determine the PII types present 
in each colonial isolate. The expression of different PIIs 
was verified in those colonies that appeared to have the 0++ 
phenotype by the SDS-PAGE. 
The following results were obtained for each GC strain 
used in this study: 
Strain WS1: Fig. 2 show the different PIIs in strain 
WS1 in a 12.5% SDS gel stained with CBB. The LPS type of 
each variant was determined by separating the whole cell 
lysates in the 15% double crosslinker SDS gel and staining 
with Silver. 
Fig. 2 A is a CBB stained gel of lysates of strain WS1. 
The PI of each variant appears to be identical on the gel. 
We isolated six PII variants in WS1. One had no PIIs (lane 
1); three of them possessed only a single PII protein (lanes 
2, 3, 4); and the other two expressed two PII proteins each 
(lane 5, 6). The molecular masses of the PIIs were 
estimated by comparison with standard molecular weight 
markers. Among the variants, we noticed PII protein bands 
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of four distinct electrophoretic mobilities. They are 24.8, 
25.2, 25.6, 26 Kd PIIs. All of the PII proteins were heat 
modifiable. At 100°C, the PII bands seen at 60° C (left) 
disappeared and the new bands appeared with higher molecular 
mass around 30 Kd. Lane 1: no PII band was seen. Lane 2: 
one PII band with a molecular mass of about 25.2 Kd 
appeared. Lane 3: the PII of this variant was about 25.6 
Kd. Lane 4: the PII of this variant was about 26 Kd. Lane 
5: two PII bands appeared. One was 25.6 Kd, the same as in 
lane 3, and the second had molecular mass of about 24.8 Kd. 
When heated at 100°C this 24.8 Kd PII band disappeared and a 
new band with molecular mass 28 Kd appeared. Lane 6: had 
two PII bands also. They were 26 and 25.6 Kd (same as lane 
4, and lane 3). 
In WS1, we found that the transparent colonies did not 
express any PIIs. The intermediated (0+) colony opacity was 
associated with 25.2 Kd PII. The rest of the PII variants 
showed the same marked (0++) colony opacity. No obvious 
differences in colony opacity were observed among these 
marked (0++) colonies which were verified to express 
different PIIs on the SDS-PAGE gel. 
Fig. 2 B shows the LPS pattern of PII variants in WS1. 
No differences were found in LPS among the PII variants. 
WS2: Like WS1, four distinctive PII protein bands were 
detected by 12.5% SDS gel with CBB staining (Fig. 3 A) . At 
60°C, from left to right. Lane 1: no PII. Lane 2: 24.8 Kd 
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PII. Lane 3: 25.2 Kd PII. Lane 4: 25.6 Kd PII. Lane 5: 26 
Kd PII. Lane 6: two PIIs 26 Kd and 25.6 Kd. All PIIs were 
heat modifiable in WS2. The 24.8 Kd PII band at 60°C moved 
to 28 Kd area at 100°C. Other PIIs moved to around 30 Kd. 
In WS2, the transparent colonies did not express any 
PIIs. Expression of the 25.2 Kd PII displayed intermediated 
colony opacity and the remaining PIIs -24.8, 26- Kd had 
marked colony opacity. 
No differences in LPS were detected among the PII 
variants in WS2 (Fig. 3. B). 
WS3: Five PII variants were selected with different 
PIIs expressed. One had no PIIs. Three of them expressed a 
single PII protein while another one expressed two PIIs at 
same time. In sum, three PII proteins (24.8, 25.2 and 26 Kd) 
were found in WS3. 
Non-PII expressing colonies were transparent while the 
expression of a 25.2 Kd PII resulted in intermediated colony 
opacity. Expression of the other two PIIs (24,8 and 26 Kd) 
resulted in marked colony opacity. No difference in opacity 
could be distinguished between them, but 12.5% SDS gel with 
CBB staining verified that different PIIs were expressed in 
these two variants. 
No differences in the LPS were found among the PII 
variants of WS3 in a 15% double crosslinker SDS gel with 
silver stain. 
WS4: Four distinctive PII bands were found with 
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molecular masses around 25.2, 25.6, 26 and 26.7 Kd in strain 
WS4 (Fig. 5 A). As with the other strains, transparent 
colonies expressed no PIIs. The expression of the 25.2 Kd 
PII resulted in an intermediate colony opacity. The other 
Pll-expressing colonies had marked colony opacity. 
A 15% double crosslinker SDS gel, stained with silver, 
revealed unexpected differences in the LPS expressed among 
the PII variants. Lane 1 and lane 4 were non-PII and 26 Kd 
PII expressing variants. Respectively, the LPS of these two 
variants migrated more slowly than the LPS of the rest of 
the PII variants on the gel. 
To further confirm the observed LPS differences in this 
strain, the new cell isolates were selected from the stock 
culture that expressed the same PIIs. The new samples from 
these isolates were analyzed by SDS-PAGE. The results were 
the same, as shown in Fig. 5 B. 
WS5: Fig. 6 A shows that only two PIIs types were 
expressed by WS5. The apparent molecular masses of these 
two PII are about 25.2 Kd (Lane 2) and 26 Kd (Lane 3). 
The LPS among the two PII variants in WS5 appeared to 
be the same on the 15% double crossliker SDS gel stained 
with silver (Fig. 6 B). 
FA102: Four types of PII variants were selected from 
FA102 (Fig. 7 A). One did not express any PIIs, the others 
expressed either the 24.8 Kd, 25.2 Kd, or 26 Kd PIIs. As 
demonstrated in the other strains, the PIIs in FA102 were 
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also heat modifiable. The 24.8 Kd PII band (at 60°C) moved 
to 28 Kd (at 100°C) . The other PII bands moved to the area 
around 30 Kd (at 100°C) . 
In FA102, transparent colonies did not express any 
PIIs. The 25.2 Kd Pll-expressing colonies had intermediate 
(0+) colony opacity and the 26 Kd PII was associated with 
marked (0*+) colony opacity. No differences in LPS were 
detected among the PII variants in FA102 on the 15% double 
crosslinker silver stained gel (Fig. 7 B). 
FA899: Six PII variants were found in strain FA899 
(Fig. 8 A), but only two colony opacities were found in this 
strain: the intermediate (0+) and marked (0++) colony 
opacities. No transparent colonies were ever observed in 
our experiments within a time period of more than six 
months. The PII " variant was selected from intermediate 
opacity colonies this was unusual, since the non-PII 
expressing colonies were transparent in the other six 
experimental strains. The other PII variants all showed 
marked colony opacity. 
Four distinct PII bands were recognized on the CBB 
stained gel. These PIIs appeared in the variants in 
different combinations. Four variants possessed only one 
PII each, 25.2, 25.6, 26 and 26,7 Kd, while the other two 
variants expressed two PIIs in each variant at the same 
time. No difference was observed in the LPS among the 
variants in FA899 with silver stained 15% double crosslinker 
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SDS gel (Fig. 8 B). 
Table III summarizes the Pll-expression of the seven 
strains used in this study. 
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Figure 1: 
Separation of WC lvsates of seven strains of N. gonorrhoea 
in 12.5% polvacrvlamide gel 
This Coomassie Brilliant blue (CBB) stained 12.5% SDS 
gel shows the migration of the Pis in the seven experimental 
strains. The major outer proteins (Pis) from strains, WS1, 
WS3, WS5 and FA102 migrated to same position in the gel, 
having a molecular mass around 36 Kd. The Pis from strains 
WS2, WS4 and FA899 also migrated to the same position in the 
gel, having a molecular mass of about 37 Kd. Molecular mass 
markers (MW) are expressed in thousands of daltons. 
36 















m: ci s 
WS1 
t u n  *  WS3 
• in u WS5 
• " Mf FA102 >• " hi a WS2 
A i > > WS4 











SDS-PAGE profiles of strain WS1 opacity variants 
Whole cells of each PII variant were solubilized at 
either 60°C and 100°C and separated in 12.5% SDS gels in the 
order of increasing apparent molecular mass of PII molecules 
at 60°C. 
A 12.5% SDS gel of 6 colony isolates (Lanes 1-6) were 
solubilized at either 60°C or 100°C and stained with 
Coomassie Brilliant blue (CBB) (Fig. 2 A). The major outer 
membrane protein PI and the outer protein lis are identified 
as (PI) and (PII) on the gel. 
A 15% double crosslinker SDS gel was stained with 
silver (SIL) to reveal Lipopolysaccharide (LPS) migration 
Fig. 2 B). Molecular mass markers (MW) are expressed in 
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FIGURE 3: 
SDS-PAGE profiles of strain WS2 opacity variants 
A 12.5% SDS gel stained with Coomassie Brilliant blue 
(BBC) shows the different PIIs in each PII variant (Fig. 3 
A). The major outer membrane protein PI and outer membrane 
II are identified as (PI) and (PII) on the gel. 
Whole cell lysates was separated in 15% double 
crosslinker SDS gel and stained with silver (SIL) to show 
the lipopolysaccharide (LPS) among the PII variants (Fig. 3 
























SDS-PAGE profiles of strain WS3 opacity variants 
The whole cell lysates of each PII variant were 
solubilized at two different temperatures (at 60°C and 100°) 
and then separated on the 12.5% SDS gel (Fig 4 A). The gel 
was stained with Coomassie Brilliant blue (CBB). The major 
outer membrane PI and outer membrane II are identified as 
(PI) and (PII) on the gel. 
The 15% double crosslinker SDS gel was used to 
separated the whole cell lysates in strain WS3 to show 
lipopolysaccharide (LPS) (Fig. 4 B). Gel was stained with 
silver (SIL). Molecular mass markers (MW) are expressed in 
thousands of daltons. 
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FIGURE 5: 
SDS—PAGE profiles of strain WS4 opacity variants 
The whole cell lysate of each PII variant, prepared at 
60°C (on the left) and 100°C (on the right) , was loaded to 
12.5% SDS gel (Fig. 5 A). We visualized the protein bands 
on the gel by staining with Coomassie Brilliant blue (CBB). 
The major outer membrane protein PI and outer membrane 
protein II are identified as (PI) and (PII) on the gel. 
The 15% SDS gel separated the whole cell lysates of the 
PII variants in strain WS4 with silver stain (SIL) to show 
the lipopolysaccharide (LPS) (Fig. 5 B). Molecular mass 
markers (MW) are expressed in thousands of daltons. 
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FIGURE 6: 
SDS—PAGE profiles of strain WS5 opacity variants. 
The samples of each PII variant in strain WS5 were 
separated on the 12.5% SDS gel (Fig. 6 A). The gel was 
stained with 0.2% Coomassie Brilliant blue (CBB). The major 
outer membrane protein PI and outer membrane protein are 
identified on the gel as (PI) and (PII). 
Lipopolysaccharide (LPS) showed on a 15% double 
crosslinker SDS gel with silver stain (SIL) (Fig. 6 B). No 
differences are seen among the PII variants in WS5. 






SDS-PAGE profiles of strain FA102 opacity variants. 
Coomassie Brilliant blue (CBB) stained 12.5% SDS gel 
show the different PII bands in each variant in the strain 
FA102 (Fig. 7 A). The abbreviations of (PI) and (PII) on 
the gel are identified as major outer membrane protein and 
outer membrane protein II. 
A double crosslinker SDS-PAGE gel with silver stain 
(SIL) show the lipopolysaccharide (LPS) in each PII variant 
(Fig. 7 B). Molecular mass markers (MW) are expressed in 





SDS—PAGE profiles of strain FA899 opacity variants. 
A Coomassie Brilliant blue (CBB) stained 12.5% SDS gel, 
showing the PIIs in the PII variants in strain FA899 (Fig. 8 
A). The abbreviation of major membrane protein and outer 
membrane II are identified as (PI) and (PII) in this Figure. 
A silver stained (SIL) 15% double crosslinker SDS gel 
shows migration of lipopolysaccharide (LPS) in the PII 
variants (Fig. 8 B). Molecular mass markers (MW) are 





The opacity (PII) variants of seven strains of GC 
PII variants 
Mol. MasPII* 
WS1 WS2 WS3 WS4 WS5 FA899 FA102 
No PII + + + + + + + 
24•8Kd + + 
25.2Kd + + + + + + + 
25.6Kd + + + + + + 
26Kd + + + + + + 















: All the samples were prepared at 60°C and separated on a 
12.5% of SDS gel with CBB stain. The molecular masses of 
PIIs in each variant were estimated by comparison with 
standard molecular weight markers. 
* : The variants express two PII types. 
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The serum sensitivity of PII variants in seven strains of GC 
There is no single technique which has emerged as a 
standard assay for determination of serum activity. The 
bewildering array of assays made meaningful comparison among 
studies very difficult. Several assays have been generally 
applied to determine the serum sensitivity of gram-negative 
bacteria. One most commonly used method is dilution plate 
assay; another is the microbactericidal assay (microassay). 
In our study, we chose the microassay method, because of the 
advantages for our particular experiments with PIIs as 
discussed in the materials and methods section. 
The NHS serum killing titers (the last serum dilutions 
that kills 100% of bacteria) for the seven strains used in 
this study were determined using the microassay in a 2-fold 
serum dilution system. The results of serum sensitivities 
for these transformant strains are shown in figure 9. 
Strain FA899 was the most serum resistant strain of all with 
a bactericidal titer 8 (100% bacteria was killed at 1:8 
serum dilution). The WS5 appeared to be the most serum 
sensitive strain with a bactericidal titer 526. WS2 was 
quite serum sensitive with a titer 256. The rest of the 
strains were comparably serum resistant, FA102 and WS4 had 
the titer 128. The WS1, WS3 had the titer 64. 
No differences were found in the serum sensitivities 
among the PII variants. As the results stated, the same 
titer was observed in all the PII variants as was seen in 
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the transparent colony types. No differences existed, which 
seemed unlikely, since previous studies by several groups 
(42, 71) had demonstrated the differences in serum killing 
that correlated with Pll-expression. 
The serum dilutions in the experiments were 2-fold. 
The differences in serum dilution between each wells become 
much larger as the dilution increased. Serum dilution of 
the first well was 1:4 and was 1:8 in the second well; the 
difference in serum dilution between those two wells was 
1:4. The difference between well 7 and 8 was 1:256, while 
the difference between wells 10 and 11 was 1:2048. The 
titers of most our experimental strains, determined by 
microassay, were quite high. This meant that the difference 
in serum dilution between each well near the titer area was 
quite large. Therefore, modest differences in killing might 
not be seen using 2-fold serum dilution. To solve this 
problem, progressively smaller dilutions were made around 
the titer for all variants of each strain. A more accurate 
new titer was found each time. Using the new titers, we 
made dilutions around them even further. As a result, the 
differences in the serum sensitivity among the PII variants 
became apparent (Table IV). 
With the individual serials smaller serum dilutions, 
the differences in the serum sensitivities among the PII 
variants have been shown (table IV). These differences in 
the serum sensitivity are well correlated with the different 
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PIIs in each variants. The transparent colonies have the 
highest serum titer, and the different isogeneic opaque 
colonies have lower titers These differences are only 
associated with PIIs expressing, not with the Pis and LPS 
changes. 
The HINHS, used as a control for all the experiments, 
was prepared by the standard method. The complement 
activity in the HINHS has been abrogated by heating to 56°C 
for 30 minutes. The results are show on Figure 9. 
In general, the bactericidal activities of NHS are 
mediated by the complement. In HINHS, the complement was 
inactivated by heating. The bactericidal activity of this 
serum should abrogated with the inactivation of the 
complement. The results from our serum test are quite 
unexpected. The HINHS has almost the same killing as the 
NHS (Fig. 9). 
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FIGURE 9: 
Microtiter bactericidal assay results from seven 
gonorrheal strains using 2-fold serum dilutions. The titers 
are the reciprocal of the last dilution killing 100% of the 
test strains. The same titer was observed for all the PII 
variants in each strain with the 2-fold serum dilutions 
system. The titer for each PII variant appeared to be the 
same. 
The bars are the mean of duplicated samples. The 
hatched bars indicates the pooled normal human serum and the 
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No differences have been found in serum sensitivities 
among the PII variants with the 2-fold serum dilution 
system. The smaller serum dilutions have been made around 
the titers that observed from 2-fold dilution for each 
strain. 
Eleven smaller serum dilutions were made in WSl around 
its bactericidal titer (64) from 1:36 to 1:116 with 1:8 
serum dilution difference between each well. The new Titers 
for each PII variant in WSl from the smaller serum dilution 
system are shown in table IV. From results, we have noticed 
that the non-PII expressing transparent colonies tend to 
have the highest titer (76), and the rest of variants have 
titers from 60 to 68. One PII variant with 25.2 Kd PII has 
the same titer (76) as the transparent colonies. 
The bactericidal titer of WS2 using the microassay in 
2-fold serum dilutions was 256 (Fig. 8). Eleven smaller 
serum dilutions were made around the titer from 1:128 to 
1:562 with 1:35 difference between each dilution. Another 
new titer (268) was found, but still no differences have 
shown in serum sensitivity among the PII variants . 
Another set of 11 smaller serum dilutions was made 
around the new titer (268) from 1:248 to 1:328. There was 
1:8 serum dilution difference between each well. With this 
secondary smaller serum dilution, the differences in the 
serum sensitivities among the PII variants finally appeared 
(table IV). We have noticed in WS2 also that the 
58 
transparent colonies tend to have the highest titer (296) 
among the PII variants. It exhibited that the transparent 
colonies were killed at greater serum dilution than that of 
other PII variants which means the transparent colonies are 
less resistant to the NHS than the rest of the PII variants. 
The serum titer for WS3 was 64 in the 2-fold serum 
dilution. Abundant growth was observed in the next well 
that had serum dilution 1:128. This suggested that the most 
accurate titers for PII variants could be located between 64 
and 128, and closer to 64. 
A set of 11 smaller serum dilutions was made from 1:32 
to 1:116 with an equal dilution difference of 1:8 between 
each well. The titer for transparent (no PII) and 25.2 Kd 
PII variant was 76, and the other two PII variants was 68. 
We tried to determine if more differences could be 
found among the PII variants in WS3. The eleven even 
smaller serum dilutions were made from 1:60 to 1:80 with 
only 1:2 serum dilution difference between each well. 
Differences in killing were observed (table IV). The titer 
for transparent colonies was 68, the other 25.2 Kd PII 
variant had the same titer as the transparent (no PII) 
colonies. The rest of PII variants had lower titers than 
the transparent colonies. 
Eleven smaller serum dilutions were made in WS4. They 
were around titer 128 (Fig. 8) with the dilutions from 1:114 
59 
to 1:194 and 1:8 apart. Results are shown on the table IV. 
The trans-parent colonies have the highest serum titer (194) 
among the PII variants. The other PII variants have lower 
serum titers than the no PII expressing colonies. Further 
dilutions were also made, but no more differences have 
appeared. I 
j 
For WS5, the titer in 2-fold dilution was 256. At this 
point, no difference in the serum sensitivity has been found 
among the PII variants. Therefore, eleven smaller dilutions 
have been made from 1:206 to 1:306. New titers for each 
variant are shown on table IV. Like other strains, the 
highest serum titer (286) has appeared in the transparent 
colonies in WS5. 
The strain FA102 had the same bactericidal titer as 
strain WS4 (Fig. 8) with 2-fold serum dilution. The same 
secondary 11 smaller serum dilutions were made as in WS4. 
The titers are shown on table IV. The highest serum titer 
(154) was also with the transparent colonies. 
Strain FA899 was very serum resistant in microasssy. 
The titer was 8 with 2-fold serum dilution. We made 8 
secondary serum dilutions from 1:4 to 1:32 and 1:4 apart. 
Secondary titers were found and showed on table IV. The 
highest serum titer in this strain was 20. The transparent 
phenotype colonies and a 26.7 Kd expressing variant had the 
same titer 20, and the rest of PII variants had lower serum 
titers. 
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Table IV : 
The serum sensitivities of PII variants to NHS 
PII VARIANTS 




WS5 FA899 FA102 
No PII 76 296 68 194 286 20 154 
24.8Kd 280 178 
25.2Kd 76 288 68 122 226 12 130 
25.6Kd 68 264 66 186 8 146 
26Kd 60 264 162 266 8 130 













A : The bactercidal titers of seven strains were not 
determined under a standard serum dilution system as Fig. 9. 
The serum dilutions were made differently for individual 
strains, but the same serum dilutions were used for all the 
variants within a single strain. 




Outer membrane proteins II (PIIs) are dominant variable 
surface structures of GC (6, 25). The functions of this 
group of proteins have not been definitively determined, but 
they are associated with pathogenesis (29, 66) and believed 
to be an important colonization factor (16, 45, 65). PIIs 
correlate with colony-opacity, and are called opacity-
associated proteins (25, 31, 88, 90, 96). The roles PIIs 
play in GC infection appear to be quite complex. 
In general, bacteria with transparent phenotype do 
not express any PIIs. Expression of different PIIs is 
associated with distinctive colony morphologies and 
opacities. Colony opacity is believed to be one of the 
reliable criteria in PII selection. However, the PIIs are 
not always associated with colony opacity. In strain JS1 
(88), one PII protein, called Plla, was not correlated with 
any colony opacities. The colonies expressing this PII 
appeared to be as transparent as the non-PII expressing 
colonies. 
In the study of seven transformant strains of GC, we 
have selected the non-PII expressing variants based on the 
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transparent phenotype. Only strain FA899 failed to express 
a transparent phenotype colonies despite the absence of any 
PIIs. The non-PII expressing variant in this strain was 
selected from the colonies which have an intermediate 
opacity, as indicated in the results section. This suggests 
that besides PIIs the other components in the membrane, such 
as LPS, may have contributed to the colony opacity in this 
strain. In majority of our experimental strains, the 25.2 
Kd PII variant generally impacted an intermediate colony 
opacity, but appeared to impact a marked colony opacity in 
FA899. 
The factor(s) that could possibly affect colony opacity 
are most likely the variable structures on the membrane. It 
is unlikely that the PI subclass contributed to the colony 
opacity. The PI proteins of each strain showed no variation 
either in migration or concentration, regardless of the PII 
variation occurring in each strain. This was true whether 
the strains expressed PIA (WSl, WS3, WS5, and FA102) or PIB 
(WS2, WS4, and FA899) (Table II). Therefore, the factor(s) 
other than Pis must contribute to the colony opacity. 
LPS, a variable membrane structure, could possibly play 
a role in colony opacity. To determine if LPS contributed 
to opacity variation, a 15% double crosslinker SDS-PAGE gel 
was strained with silver to examine LPS in all PII variants. 
No difference in LPS was revealed in six strains with the 
exception of strain WS4, in which the LPS patterns in two 
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PII variants were different (Fig. 5 B), with the LPS in the 
non-PII expressing colony (Lane 1) and 26 Kd PII (Lane 3) 
being different from others. The LPS in these two PII 
variants moved slower than the LPS in the rest of the 
variants in this strain. However, no correlation could be 
found between LPS differences and the difference in colony 
opacity. If LPS had affected the colony opacity, it would 
likely have shown up in the non-PII expressing transparent 
colonies. We also has not found any differences in LPS 
among the PII variants in FA899 which never did express the 
transparent colony opacity phenotype. No changes have been 
observed in colony opacity in these colonies, indicating 
that LPS did not influence colony opacity. Therefore, it 
seems that LPS did not influence colony opacity in our 
experiments. Since we did not do extensive studies to 
identify LPS variation within our strains, it is still 
possible that LPS variation could influence colony opacity. 
In WSl, four distinctive PIIs are found. They are 24.8, 
25.2, 25.6, 26 Kd. WSl was a spontaneous pyocinR mutant of 
FA102 (Table I). In FA102, except for the transparent non-
PII expressing colony, three PIIs, (25.2, 25.6, 26 Kd) were 
found. Comparing the PIIs in these two strains, one 
additional (24.8 Kd) PII has appeared in WSl that has not 
been found in FA102. Since FA102 was considered to be the 
only parent of WSl, we assumed that the DNA sequence code 
for 24.8 Kd PII probably also existed in the FA102. 
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However, we have not successfully selected this PII. 
The PII gene could exist in the genome of FA102 in the 
form of an unexpressed gene or it might exist as a partial 
gene, which could not express itself except by recombining 
with homologous sequences in another complete genes (seminar 
of J. Swanson). The reasons that the 24.8 Kd PII was not 
found in FA102 could possibly be: We simply missed this PII 
while we selecting the PII variants; special conditions 
might be needed for expression of this PII protein; or 
promoter of this gene was inactivated, so the gene can no 
longer to be expressed. It is also possible that a 
recombination event occurred in the DNA sequence of WSl 
along with the mutation in the gene which controls the 
pyocin resistance. If so, the 24.8 Kd PII gene might have 
been created during the process. This raises several 
unanswered questions about the stability and expression of 
PII genes that are beyond the scope of this study. 
WS2 has two parent strains, FA899 and WSl. Each 
parental strain has four PIIs. Three of them were common to 
both parents and were also expressed in the daughter strain 
WS2 (25.2 Kd, 25.6 Kd and 26 Kd). The other two were unique 
in each parental strain, with WSl expressing a 24.8 Kd PII 
and FA899 a 26.7 Kd PII. The (24.8 Kd) PII in WSl also has 
been seen in the daughter strain WS2. But the 26.7 Kd PII 
that was expressed in another parent FA899 has not been 
found in WS2. 
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PII genes from both parents could be transferred to the 
daughter strain. It is possible that the DNA sequence for 
this 26.7 Kd PII was transferred from the parent FA899 to 
daughter WS2, but due to present of suppressor, loss of 
correct promoter or intervening sequence was not expressed. 
Conversely, the sequence may not has been successfully 
transferred to the daughter gamone. This could be tested by 
several methods; We have learned , when bacteria are grown 
under different stresses, the cell can change its gene 
expression, as the cell under heat shock. Suppressed genes 
could be turned on and the others could be turned off. We 
can put strain WS2 under different stresses to see whether 
or not this 26.7 Kd PII can be expressed. The positive 
result would confirm the existence of the gene, but the 
negative result does not necessarily mean the absence of 
this gene. Another new technique allows us sequencing of 
the PII genes in WS2 or specific probes can be used to 
detect the existence of the gene in the gamone. 
All the PIIs expressed by WS2 were also expressed in 
its parental strains. No new PIIs were found in the progeny 
(WS2) that were not also found in the parental strains 
(FA899 or WSl). 
WS3 has the same parents (WSl and FA899) as WS2. In 
WS3, three PIIs have been selected. They are 25.2, 25.6, 
and 26.7 Kd. The 26.7 Kd PII expressed in parent FA899 that 
has not found in one daughter strain WS2 was shown up in 
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WS3. Two 26.7 Kd PII expression variants have been found in 
WS3, one express only 26.7 Kd PII and another express two 
PIIs, 26.7 and 25.2 Kd. It seems that 26.7 Kd PII was 
actively expressed in WS3. 
Comparing the PII expression parterns in WS2 and WS3, 
the 26.7 and 24.8 Kd PIIs was not expressed in same strain. 
Another 26.7 Kd expression strain FA899, 24.8 Kd PII has 
also not found. The 24.8 Kd PII was expressed in WS4, 26.7 
Kd PII was also not selected from this strain. This may 
imply a possible relationship between those two genes, 
expression of one gene inhibited the expression of another. 
WS4 has WS2 and FA102 as the parental strains. In 
addition to the transparent variant (no PII), three (24.8, 
25.2, 26 Kd) PIIs have been identified in WS4. All of them 
have also appeared in the parents. 
WS5 has the same parents as WS4 as shown in Table I. 
Only two PIIs have been selected from this strain. Fewer 
PIIs were found in this strain than in either of its parents 
(WS2 and FA102). 
Expression of PIIs is controlled by a group of opa 
genes, which are spread throughout the gonococcal genome 
(77). These genes can be turned on and off at a very high 
frequency depending on the number of CTCTT (RC) sequences in 
the leader sequence. The number of RC sequences causes a 
frameshift within the gene which can either put the PII gene 
in or out of frame with ATG initiation codon, so either a 
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functional PII protein or a truncated PII protein could be 
synthesized. The mechanisms that control the high frequency 
changes in the number of CTCTT sequences in PII mRNA are 
still poorly understood. They could possibly result from 
the slippage or stuttering of RNA polymerase as the genes 
are transcribed. The unequal crossing-over among the signal 
peptide coding regions of different PII genes that causes 
the insertion or deletion of RC repeat units could also be 
responsible for the changes in the number of RC sequences. 
Using gene sequencing and common PII gene probe 
techniques, many more PII genes have been identified in the 
genome than the PIIs have expressed (77). This indicates a 
lot more PII genes remain in an inactive state in the 
genome. Different genetic movements have been detected 
among PII genes: Gene duplication and conversion generate 
new PII coding sequences and increase the structural 
variability in the proteins PII family (93); the genetic 
transformation of PII genes from donor to the recipient are 
confirmed by using MABs (73). These genetic movements could 
occur among genes within the genome, or between different 
cells, creating many opportunities for new PII coding 
sequences. However, our experiments did not identify any 
new PIIs expressed in the daughter strains that were not 
also expressed in parental strains. It is possible that new 
PII genes have been created but remain unexpressed in the 
genome. Those PII genes exist in the genome in an inactive 
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state (48) when the bacteria are grown under the certain 
conditions. The cells retain the ability to express those 
PIIs when it becomes necessary. This could be confirmed by 
comparing PII expressing patterns of a single strain under 
different growth conditions. However, the mechanisms that 
prevent PII genes from being expressed under certain 
conditions and allow them to be expressed under others are 
still not well characterized. 
From PIIs expressing patterns of our experimental 
strains, we have noticed that almost all PIIs expressed in 
daughter strains were also found in at least one of their 
parents. There were not as many as PIIs expressed in each 
daughter strains, as we expected. It is likely that gene 
products from a particular gene could serve as suppressor 
preventing expression of another gene. 
OM proteins II, the colony opacity associated protein 
on the surface of GC, are not the only structure that could 
contribute to the colony opacity. The possible involvement 
of LPS has not been confirmed in our experiments. The 
possibility of PII genes existing in an inactive state in 
the genome is proposed. Those PII genes can be expressed at 
different environmental conditions which could increase 
bacterial survival and help bacteria evade the host immune 
response. In efforts to evaluate whether many more PIIs 
could be expressed in each strain, future experiments will 
observe the PII expression of strains under different growth 
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conditions. 
Serum resistance is a common phenomenon of gram-
negative bacteria that has been recognized for many years. 
Surprisingly little is know about the molecular mechanisms 
involved. Like many gram-negative bacteria, differences in 
serum resistance have been observed among different strains 
of GC. Adding to the difficulties in determining molecular 
factors which contribute to serum resistance is the 
variability of results, depending on the bactericidal assay, 
the definition of serum resistance (indicated as 90% of 
survival, 80% of survival or 20% of survival), the serum 
concentration and the source of serum. As mentioned in the 
material and method section, we chose the microassay method 
instead of dilution plate assay method for the advantages of 
this method in our particular experiment. 
Many studies have examined the bactericidal actions of 
NHS as a function of colony phenotypes (49, 60), OM protein 
I (29) and LPS (92), the important structures on the surface 
of the cell which have been associated with serum 
sensitivity. Our studies have been focused on another group 
of OM proteins (PIIs). 
Previous research indicates that the proteins II on the 
surface of GC could affect the serum killing and might be 
one important factor in determining the serum sensitivity 
(29, 46). The serum sensitivities are determined by the 
presence of the bacterial surface structures which are 
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capable of interfering with the formation, attachment, and 
subsequent activity of the MAC formed by complements cascade 
(91). In our serum test, it seems that the bactericidal 
activity in the microassay measures both complement-mediated 
killing and a non-complement-mediated killing mechanism. 
Differences in serum sensitivity of non-PII bearing 
bacteria has been determined in our seven transformant 
experimental strains (Fig. 9). Our data showed that strain 
WS5 was a very serum sensitive strain; it is counted as a 
serum resistant strain in table I (the results from dilution 
plate assay). WS4 and FA102 are serum resistant strains in 
table I, but appeared to be quite sensitive in our test. 
Those differences were caused by the different methods used 
to test the serum sensitivity. The serum concentration used 
and the time incubate bacteria with serum are quite 
different in these two methods. 
Different serum titers have been obtained among the PII 
variants with the secondary smaller serum dilution. The 
transparent colonies (having no PII) tended to have higher 
killing titer than their isogeneic opaque colonies, 
indicating that transparent colonies were more sensitive to 
the NHS than opaque colonies. It suggests that expression 
of PIIs enhanced the ability of these strains to resist to 
killing by NHS. 
Previous reports showed PI and LPS were both 
significant in determining the serum sensitivity (29, 75). 
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In our experimental strains, the Pis appeared to be 
invariable among the PII variants (identical migration on 
the SDS gel). The LPS shown on a 15% double crosslinker SDS 
gel with silver stain revealed no differences in LPS 
structure with the exception of strain WS4. In strain WS4, 
different LPS patterns were seen in non-PII expressing 
colonies and the variant express 26 Kd PII. However, these 
differences were not associated with differences in serum 
sensitivities. The transparent colonies were still the most 
serum sensitive among the PII variants. Therefore, LPS 
variation did not contribute to the differences in serum 
sensitivity in this strain. No conclusions can be made 
based on these LPS variations. As mentioned before, WS2 and 
WS3 have the same parents, a large difference in serum 
sensitivity has been observed with the same PII expression 
variants in those two strains. This suggests that PI or PI 
combining with LPS are important in affecting serum 
sensitivity among strains. 
Our results demonstrated that variation in PII 
expression has contribute to the variation in serum 
sensitivity, and that PIIs rather than the LPS or Pi-type 
contributed to the variations in serum killing within each 
strain. 
The results from our microassay serum tests contradict 
a previous report which suggested the opaque colonies were 
less resistant to the NHS than the isogeneic transparent 
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colonies (29). However, our data supports another report 
which demonstrated that the expression of PII increased 
serum resistance (46). Results from our serum test 
indicated that the transparent colonies were more sensitive 
to the NHS than the isogeneic opaque colonies. We have 
found no relationship between a specific PII and the 
greatest serum resistance within our experimental strains 
We have used the heat-inactivated normal human serum 
(HINHS) as one of the controls in our experiment. 
Therefore, we did not expect to see significant killing with 
this serum with no complement activity, as we believed that 
the serum killing of gram-negative bacteria is mediated by 
the complement (68, 75, 91). The inactivation of the 
complement should abrogate the bactericidal activity of NHS. 
The results from our serum tests with microassay 
indicated that HINHS was not only bactericidal to all the 
experimental strains, but also had almost as much killing as 
intact NHS (Fig. 9). In an effort to understand this 
phenomenon, a set of experiments were performed by using 
HINHS with human complement added back (data not shown). We 
hoped to determine if the complement played the same role in 
microassay as it did in other serum assays, or if other 
unknown mechanisms were involved in the killing in the 
microassay method. Surprisingly, no difference in serum 
killing has been observed using HINHS with human complement 
adding back, suggesting that the bactericidal activities in 
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microassay were mediated by mechanisms other than the 
activation of complement. The substance contributed to the 
serum killing in HINHS must be heat stable, since the 
bactericidal activity existed after heating the serum at 
56°C for 30 minutes. 
The same phenomena was also discovered by a colleague 
in our lab (61). She discussed two possibilities: The 
killing could be mediated by 1). toxic fatty acids or 2). 
specific Abs. The bactericidal capacity of HINHS (the c'-
depleted serum) was not affected by doubling the amount of 
soluble starch in the medium which could bind to and 
neutralize toxic fatty acids, nor decreased by pre-absorbing 
the serum with the test strain of GC to get rid of specific 
Abs. 
Besides the complement, toxic fatty acids and specific 
Abs, several other substances in the serum could possibly 
contribute the serum killing. A group of low-molecular-
weight cationic proteins in the serum termed /?-lysins 
possess lethal activity against gram-positive bacteria (91) 
and some gram-negative bacteria at very high concentration. 
/J-lysins appear to be heat stable (52), and are released 
from platelets during the process of blood coagulation. It 
is believed that the primary site of action for /3-lysins is 
the cytoplasmic membrane. No direct lethal action has been 
observed against gram-negative bacteria 
possessing an integral envelope structure. However, GC is 
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well know to have a "leaky " outer membrane structure; the 
outer membrane of GC was more permeable than the other 
members in the Enterobacteriaceae family (penicillin can 
penetrate OM and kill GC but not effect most gram-negative 
bacteria) (52). Perhaps, this explained our observation. 
The data from our experiments provide direct evidence 
of the relationships among the PII variants and their 
isogeneic transparent colonies in the serum 
susceptibilities. Expressing of PIIs in the GC outer 
membrane could not only increase the attachment of bacteria 
to different host cells which help establish infection but 
also increase serum resistance which enhance bacterial 
survival in the internal environments. PIIs are important 
not only in GC infection but also in bacterial survival. 
Thus, serum killing in microassay appears unusual; 
potentially a group of heat stable low-molecular-weight 
cationic proteins in the serum may be involved. 
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SUMMARY 
Outer membrane protein II (PII) of Neisseria 
gonorrhoeae is recognized by their ability to affect colony 
opacity. Our studies on expression of PII in seven strains 
indicate that PII is important in affecting colony opacity, 
but not the only factor. A variable surface structure, 
lipopolysaccharide (LPS) may play a role in colony opacity; 
however, result suggests that effects of LPS on colony 
opacity are minimal. 
The serum sensitivities of different PII variants in 
each strain were examined. Despite the evidence that 
gonococcal resistance to normal human serum is 
multifactorial, the use of isogeneic variants shown OMP II 
is associated with considerable serum resistance. 
The serum bactericidal microassay tests the different 
killing aspects of the normal human serum (NHS), it was 
revealed by using the complements abrogated serum (heat-
inactivated normal human serum). This suggests that serum 
killing in the microassay method likely mediated by a group 
of heat stable low-molecular-weight cationic proteins termed 
0-lysins. These serum proteins released from platelets 
during process of blood coagulation. 
76 
LITERATURE CITED: 
1. Barrera, O., and J. Swanson. 1984. Proteins IA and IB 
exhibit different Surface exposures and orientations in 
the outer membranes of Neisseria gonorrhoeae. Infect. 
Immun. 44:565-568 
2. Barritt, D. S., R. S. Schwalbe, D. 6. Flapper, and J. 
6. Cannon. 1987. Antigenic and Structural Differences 
among Six Proteins II Expressed by a Single Strain of 
Neisseria gonorrhoeae. Infect. Immun. 55:2026-2031 
3. Bessen, D., and E. C. Gotschlich. 1987. Chemical 
Characterization of Binding Properties of Opacity-
Associated Protein II from Neisseria gonorrhoeae. 
Infect. Immun. 55:141-147 
4. Black, W. J., R. s. Schwalbe, I. Nachamkin, and J. G. 
Cannon. 1984. Characterization of Neisseria 
gonorrhoea Protein II Phase Variation By Use of 
Monclonal Antibodies. Infect. Immun. 45:453-457 
5. Blake, M. S., E. C. Gotschlich, and J. Swanson. 1981. 
Effects of proteolytic enzymes on the out Membrane 
Proteins of Neisseria gonorrhoeae. Infect. Immun. 
33:212-222 
6. Blake, M. S., and E. C. Gotschlich. 1984. Purification 
and partial characterization of the Opacity-Associated 
Proteins of Neisseria gonorrhoeae. J. Exp. Med. 
159:452-462 
7. Britigan, B. E., M. S. Cohen, and P. F. Sparling. 
1985. Gonococcal Infection: A Model of Molecular 
Pathogeneses. New Eng. J. Med. 312:1683-1694 
8. Brown, W. J. MSPH., and S. J. Kraus. 1974. Gonococcal 
Colony Types. JAMA 228:862-863 
9. Cannon, J. G., T. J. Lee, L. F. Guymon, and P. F. 
Sparling. 1981. Genetics of Serum Resistance in 
Neisseria gonorrheae: The sac-1 Genetic Locus. 
Infect. Immun. 32:547-552 
10. Cannon, J. G., w. J. Black, I. Nachamkin, and P. w. 
Stewart. 1984. Monoclonal Antibody that Recognizes an 
outer membrane Antigen Common to the Pathogenic 
Neisseria Species but not to most nonpathogenic 
Neisseria Species. Infect. Immun. 43:994-999 
77 
11. Centers for Disease Control. 1988. Summary of 
notifiable diseases, United States. 1987. Morbid. 
Mortal, weekly Rep. 36:841 
12. Connell, T. D., W. J. Black, T. H. Kawula, and D. S. 
Barritt. 1988. Recombination among Protein II Genes 
of Neisseria gonorrhoeae Generates New Coding sequences 
and increases Structural variability in the Protein II 
family. Molecular Microbiology. 2(2):227-236 
13. Connell, T. D., D. Shaffer, and J. G. Cannon. 1990. 
Characterization of the repertoire of hypervariable 
regions in the Protein Il(opa) gene family of Neisseria 
gonorrhoeae Molecular Microbiology. 4(3):4439-449 
14. Diaz, J. L., and J. E. Heckels. 1982. Antigenic 
Variation of Outer Membrane Protein II in Colonial 
Variants of Neisseria gonorrhoeae P9. J. Gen. 
Microbiology. 128:585-591 
15. Darward, D. W., C. F. Garon, and R. C. Judd. 1989. 
Export and Intercellular Transfer of DNA Via Membrane 
Blebs of Neisseria gonorrhoeae. J. of Bacterial. 
171:2499-2505 
16. Fischer, S. H., and R. F. Rest. 1988. Gonococci 
Possessing Only Certain P. II Outer Membrane Proteins 
Interact with Human Neutrophils. Infect. Immun. 
56:1574-1579 
17. Frank, M. M., K. A. Joiner, and C. H. Hammer. 1987. 
The Function of Antibody and Complement in the Lysis of 
Bacteria. Reviews Infect. Dis. 9:S537-545 
18. Gibbs, C. P., B. Y. Remann, E. Shultz, A. Kaufmann, R. 
Haas, and T. F. Meyer. 1989. Reassortment of Pilin 
Genes in Neisseria gonorrhoeae Occurs by two distinct 
Mechanisms Nature. 338:651-6528. 
19. Glynn, A. A., and M. E. Ward. 1970. Nature and 
Heterogeneity of the Antigens of Neisseria gonorrhoeae 
Involved in the Serum Bactericidal Reaction. Infect. 
Immun. 2:162-168 
20. Gotschlich, E. C., M. s. Blake, J. M. Koomey, M. seiff, 
and A. Derman. 1986. Cloning of the Structural Genes 
of Three H8 Antigens and of Protein III of Neisseria 
gonorrhoeae. J. Exp. Med. 164: 868-881 
21. Guymon, L. F., M. Esser, and w. M. Shafer. 1982. 
Pyocin-Resistant Lipopolysaccharide Mutants of 
Neisseria gonorrhoea: Alterations in Sensitivity to 
78 
Normal Human Serum and Polymyxin B. Infect. Immun. 
36:541-547 
j 
22. Hagblom, P., E. Segal, E. Billyard, and M. So. 1985. 
intragenic Recombination Leads to Pilus Antigenic 
Variation in Neisseria gonorrhoeae. Nature 315:156-
158 
23. Harriman, G. R., E. R. Podack, A. I. Braude, L. C. 
Corbeil, A. F. Esser, and J. 6. Curd. 1982. 
Activation of Complement by Serum-Resistant Neisseria 
gonorrhoeae. J. Exp. Med. 156:1235-1249 
24. Heckels, J. E., B. Blackett, J. S. Everson, and M. E. 
Ward. 1976. The Influence of Surface Charge on the 
Attachment of Neisseria gonorrhoeae to Human Cells. J. 
Gen. Microbiol. 96:359-364 
25. Heckels, J. E. 1977. The Surface Properties of 
Neisseria gonorrhoeae: Isolation of the Major 
Components of the Outer Membrane. J. Gen. Microbiol. 
99:333-341 
26. Heckels, J. E. 1978. The Surface Properties of 
Neisseria gonorrhoea: Topographical Distribution of the 
Outer Membrane Protein Antigens. J. Gen. Microbiol. 
108: 213-219 
27. Heckels, J. E. 1981. Structural Comparison of 
Neisseria gonorrhoeae Outer Membrane Proteins. J. 
Bacteriol. 145:736-742 
28. Holmes, K. K., P. A. Mardh, P. F. Sparling, and P. J. 
Wiesner. 1984. Sexually transmitted disease. P187-204 
29. James, J. F., E. Zurlinden, C. J. Lammel, and G. F. 
Brooks, 1982. Relation of protein I and colony 
Opacity to Serum Killing of Neisseria gonorrhoeae. J. 
Infect. Dis. 145:37-44 
30. James, J. F., and J. Swanson. 1978. Studies in 
Gonococcus Infection XIII. Occurrence of Color/Opacity 
Colonial Variants in Clinical Cultures. Infect. Immun. 
19:332-340 
31. Johnston, K. H., K. K. Holmes, and E. C. Gotschlich. 
1976. The Serological Classification of Neisseria 
gonorrhoeae. Isolation of the outer membrane complex 
responsible for serotypic specificity. J. Exp. Med. 
143:741-758 
32. Joiner, K. A., R. C. Goldman, C. H. Hammer, L. leive, 
79 
and H. H. Frank. 1983. Studies of the Mechanism of 
Bacterial resistance to Complement-Mediated Killing. V. 
IgG and F(ab')2 Mediate Killing of E. Coli 0111B4 by 
the Alternative Complement Pathway without Increasing 
C5b-9 Deposition. J. Immun. 131:2563-2569 
33. Joiner, K. A., R. c. Goldmen, C. H. Hammer, L. Leive, 
and M. M. Frank. 1983. Studies on the Mechanism of 
Bacterial Resistance to Complement-Mediated Killing. 
VI. IgG Increases the Bactericidal Efficiency of C5b-9 
for £. Coli 0111B4 by Acting a Step Before C5 Cleavage. 
J. Immun. 131:2570-2575 
34. Joiner, K. A., K. A. Warren, E. J. Brown, J. Swanson, 
and M. M. Frank. 1983. Studies on the Mechanism 
of Bacterial Resistance to Complement-Mediated Killing. 
IV. C5b-9 Forms High Molecular Weight Complexes With 
Bacterial Outer Membrane Constituents of Serum-
Resistant but not on Serum-Sensitive Neisseria 
gonorrhoeae. J. Immun. 131:1443-1451 
35. Joiner, K. A., R. Scales, K. A. Warren, M. M. Frank, 
and P. A. Rice. 1985. Mechanism of Action of Blocking 
IgG for Neisseria gonorrhoea. J. Clin. Invest. 76: 
1765-1772 
36. Judd, R. C. 1982. Surface Peptide Mapping of Protein 
I and Protein III of four strains of Neisseria 
gonorrhoeae. Infect. Immun. 37: 632-641 
37. Judd, R. C. 1985. Structure and Surface Exposure of 
Protein lis of Neisseria gonorrhoeae JS3. Infect. 
Immun. 48:452-457 
38. Judd, R. C. 1986. Evidence for N-Terminal Exposure of 
the Protein IA Subclass of Neisseria gonorrhoeae 
Protein I. Infect. Immum. 54:408-414 
39. Judd, R. C., M. Tam, and K. A. Joiner. 1987. 
Characterization of Protein I from Serum-Sensitive and 
Serum Resistant Transformants of Neisseria gonorrhoea. 
Infect. Immum. 55:273-276 
40. Judd, R. C. 1989. Protein I: Structure, Function, and 
Genetics. Clin. Microbiol. Reviews. Ps41-s48 
41. Judd, R. C., and W. M. Shafer. 1989. Topographical 
alterations in proteins I of Neisseria gonorrhoeae 
correlated with lipopolysaccharide Variation. 
Molecular Microbiol. 3(5):637-643 
80 
42. Kellogg, D. 8., W. L. Peacock, W. E. Deacon, L. Brown, 
and C. L. Pirkle. 1963. Neisseria gonorrhoeae. I. 
Virulence Genetically Linked to Clonal Variation. J. 
Bacterid. 85:1274-1279 
43. Killogg, D. Sf I. R. Cohen, Ii. C. Norms, A. li. 
Schroeter, and G. Reising. 1968. Neisseria 
gonorrheae. II. Colonial Variation and Pathogenicity 
during 35 months in Vitro. J. Bacteriol. 96:596-605 
44. Knapp, J. S., E. G. Sandstrom, and K. K. Holmes. 1985. 
Overview of Epidemiological and Clinical Applications 
of Auxotype/Serovar Classification of Neisseria 
gonorrhoeae in the Pathogenic Neisseria. G. K. 
Schoolnik, Editodr American Society for Microbiology, 
Washington, D. C. 6-12 
45. Lambden, P. R., and J. E. Heckels. 1979. Outer 
Membrane Protein Composition and Colonial Morphology of 
Neisseria gonorrhoeae strain P9. FEMS Microbiol. 
5:263-265 
46. Lambeden, P. R., J. E. Heckels, L. T. James, and P. J. 
Watt. 1979. Variations in Surface Protein Composition 
Associated with Virulence Properties in Opacity Types 
of Neisseria gonorrhoeae. J. Gen. Microbiol. 
114:305-312 
47. Lavitola, A., P. M. W. Martin, Y. Pean, M. 
Guibourdenche, and J. Y. Riou. 1984. Stable Serum 
Resistance of Neisseria gonorrhoeae as an 
Epidemiological Marker. Br J Vener Dis. 60:298-301 
48. Mayer, L. W. 1982. Rates of In Vitro changes of 
Gonococcal Colony Opacity Phenotypes. Infect. Immun. 
37:481-485 
49. McCutchan, J. A., S. Levine, and A. I. Braude. 1984. 
Influence of Colony Type on Susceptibility of Gonococci 
to Killing by Human Serum. J. Immun. 116:1652-1655 
50. Mills, J., and G. F. Brooks. 1984. Disseminated 
Gonococcal infection. P229-237. in K. K. Holmes, P.-
A. Mardh (ed.). Sexually transmitted Diseases, 
McGraw-Hill Co. New York, New York. 
51. Mintz, C. S., M. A. Apicella, and s. A. Morse. 1984. 
Electrophoretic and Serological Characterization of the 
Lipopolysaccharide Produced by Neisseria gonorrhoeae. 
J. Infect Dis. 149:544-552 
52. Morse, S. A., A. F. Cacciapuoti, and P. G. Lysko. 
81 
1978. Physiology of Neisseria gonorrhoeae. 251-317 
53. Murphy, 6. L., T. D. Connell, D. S. Barritt, M. Koomey, 
and J. 6. Cannon. 1989. Phase Variation of gonococcal 
Protein II: Regulation of Gene Expression by Slipped-
Strand Mispairing of a Repetitive DNA Sequence. Cell. 
56:539-547 
54. Nevhall w. J., L. B. Mail, c. E. Wilde, and R. B. 
Jones. 1985. Purification and Antigenic Relatedness 
of Proteins II of Neisseria gonorrhoeae• Infect. 
Immun. 49:576-580 
55. Nicolson, I. J., A. C. F. Perry, J. E. Heckels, and J. 
Saunders. 1987. Genetic Analysis of Variant Pilin 
Genes from Neisseria Gonorrheae P9 Cloned in 
Escherichia Coil: Physical and Immunological Properties 
of Encoded Pilins. J. Gen. Microbiol. 133:553-561 
56. Norrod, E. P. 1982. Phenotypic changes in colonial 
morphology of Neisseria gonorrhoeae. Can. J. 
Microbiol. 28:1265-1272 
57. Morrod, E. P. 1983. Induced changes in the surface of 
Neisseria gonorrhoeae. Can. J. Microbiol. 29:584-592 
58. Palmer, L., G. F. Brooks, and S. Falkow. 1989. 
Expression of gonococcal Protein II in Escherichia coli 
by Translation Fusion. Molecular Microbiology. 
3(5):663-671 
59. Pearce, W. A., and T. M. Buchanan. 1978. Attachment 
Role of Gonococcal Pili. J. Clin. Invest. 61:931-943 
60. Penn, C. W., D. R. Veale, and H. Smith. 1977. 
Selection from Gonococci Grown in vitro of a Colony 
Type with some Virulence Properties of Organisms 
Adapted in vivo. J. Gen. Microbiol. 100:147-158 
61. Pettit, R. K., J. C. Sauba, and R. C. Judd. 1990. 
Comparison of two Serum Bactericidal Assays for 
Neisseria gonorrhoeae. J. Immun. Method. 129:15-22 
62. Rest, R. F., N. Lee, and C. Bowden. 1985. Stimulation 
of Human Leukocytes by Protein II+ Gonococci Is 
Mediated by Lectin-Like Gonococcal Components. Infect. 
Immun. 50:116-122 
63. Rice, P. A., H. E. Vayo, M. Tarn, and M. S. Blake. 
1986. Immunoglobulin G Antibodies Directed Against 
Protein III Block Killing of Serum-Resistant Neisseria 
82 
Gonorrhoeae by Immune Serum. J. Exp. Med. 
164:1735-1748 
64. Robertson, J. N., p. vincert, and M. E. Ward. 1977. 
The Preparation and Properties of Gonococcal Pili. J. 
Gen. Microbiol. 102:169-177 
65. Robinson, E. N., C. M. Clemens, Z. A. McGee, and J. G. 
Cannon. 1988. Immunoelectron Microscopic Localization 
of Outer Membrane Proteins II on the Surface of 
Neisseria gonorrhoeae. Infect. Immun. 56:1003-1006 
66. Salit, I. E., and E. C. Golschlich. 1978. Gonococcal 
Color and Opacity Variants Virulence for Chicken 
Embryos. Infect. Immun. 22:359-364 
67. Schneider, H., and J. M. Griffiss. 1982. A 
Bactericidal Microassay for Testing Serum Sensitivity 
of Neisseria gonorrhoeae. J. Immun. Meth. 54:101-105 
68. Schneider, H., J. M. Griffiss, G. D. Williams, and 
G. B. Pier. 1982. Immunological Basis of Serum 
Resistance of Neisseria gonorrhoea. J. Gen. Microbiol. 
128:13-22 
69. Schneider, H., J. M. Griffiss, R. E. Mandrell, and G. 
A. Jarvis. 1985. Elaboration of a 3.7 Kilodalton 
Lipopolysaccharide, Antibody against Which Is absent 
from Human Sera, Is Associated with Serum resistance of 
Neisseria gonorrhoeae. Infect. Immun. 50:672-677 
70. Schoolnik, J. K., T. M. Buchanan, and K. K. Holmes. 
1976. Gonococci Causing Disseminated Gonococcal 
Infection Are Resistant to the Bactericidal Action of 
Normal Human Sera. J. Clin. Invest. 58:1163-1173 
71. Schoolnik, J. K., R. Fernandez, J. Y. Tai, J. Rothbard, 
and E. C. Gotschich. 1984. Gonococcal Pili. Primary 
Structure and Receptor Binding Domain. J. Exp. Med. 
159:1351-1370 
72. Schwalbe, R. S., P. F. Sparling, and J. G. Cannon. 
1985. Variation of Neisseria gonorrhoeae Protein II 
among Isolates from an Outbreak Caused by a Single 
Gonococcal Strain. Infect. Immun. 49:250-252 
73. Schwalbe, R. S., and J. G. cannon. 1986. Genetic 
Transformation of Genes of Protein II in Neisseria 
gonorrhoeae. J. Bacteriol. 167:186-190 
83 
74. Segal, E., E. Billyard, M. So, S. Storzbach, and T. F. 
Meyer. 1985. Role of Chromosomal Rearrangement in 
Neisseria gonorrhoeae Pilus Phase Variation. Cell. 
40:293-300 
75. Shafer, W. M., K. A. Joiner, L. F. Guymon, M. s. Cohen, 
and P. F. Sparling. 1984. Serum Sensitivity of 
Neisseria gonorrhoea: The Role of Lipopolysaccharide. 
J. Infect. Dis. 149:175-183 
76. Sparling, P. F., J. G. Cannon, and M. So. 1986. Phase 
and antigenic variation of Pili and Outer Membrane 
Protein II of Neisseria gonorrheae. J. Infect. Dis. 
153:196-200 
77. Stern, A., M. Brown, P. Nickel, and T. F. Meyer. 1986. 
Opacity Genes in Neisseria gonorrhoea: Control of Phase 
and Antigenic Variation. Cell. 47:61-71 
78. Stern, A., and T. F. Meyer. 1987. Common Mechanism 
Controlling Phase and Antigenic Variation in Pathogenic 
Neisseriae. Molecular Microbiology. 1:5-12 
79. Stritnatter, W., and P. J. Hitchcock. 1986. Isolation 
and characterization of gonococcal H8 Antigen. Abstract 
IV-101, 5th International Pathogenic Neisseria 
Meetings, Noordwijkerhout, The Netherlands. 
80. Strittmatter, W. and P. J. Hitchcock. 1986. Isolation 
and Preliminary Biochemical Characterization of the 
Gonococcal H.8 antigen. J. Exp. Med. 164:2038-2048 
81. Sugasawara, R. J., J. G. Cannon, W. J. Black, I. 
Nachamkin, R. L. Sweet, and G. F. Brooks G. F. 1983. 
Inhibition of Neisseria gonorrhoeae Attachment to Hela 
Cells with Monoclonal Antibody directed Against a 
Protein II. Infect. Immun. 42:980-985 
82. Swanson, J., S. J. Kraus, and E. C. Getschlick. 1971. 
Studies on Gonococcus Infection. I. Pili and zones of 
Adhesion: Their Relation to the Gonococcal Growth 
Patterns. J. Exp. Med. 134:886-906 
83. Swanson, J. 1973. Studies on Gonococcus Infection IV. 
Pili: Their role in Attachment of Gonococcus to Tissue 
Culture Cells. J. Exp. Med. 137:571-589 
84. Swanson, J. 1978. Studies on Gonococcus Infection 
XII. Colony Color and Opacity Variants of Gonococci. 
Infect. Immun. 19:320-331 
84 
85. Svanson, J. 1978. Studies on Gonococcus Infection 
XIV. Cell Wall Protein Differences Among Color/Opacity 
Colony Variants of Neisseria gonorrhoeae. Infect. 
Immun. 21:292-302 
86. Swanson, J. 1980. 125I-Labeled Peptide Happing of Some 
Heat-Modifiable Proteins of the Gonococcal Outer 
Membrane. Infect. Immun. 28:54-64 
87. Swanson, J. 1981. Surface exposed Protein Antigen of 
the gonococcal outer membrane. Infect. Immun. 
34:804-816 
88. Swanson, J. 1982. Colony Opacity and Protein II 
Compositions of Gonococci. Infect. Immun. 37:359-368 
89. Swanson, J., and O. Barrera. 1983. Immunological 
Characteristics of gonococcal Outer Membrane Protein II 
Assessed by Immunoprecipitation, Immunoblotting, and 
Coagglutination. J. Exp. Med. 157:1405-1420 
90. Swanson, J., O. Barrera, J. Sola, and J. Boslego. 
1988. Expression of Outer Membrane Protein II by 
Gonococci in Experimental Gonorrhea. J. Exp. Med. 
168:2121-2129 
91. Taylor, P. W. 1983. Bactericidal and Bacteriolytic 
Activity of Serum Against Gram-Negative Bacteria. 
Microbiol. Reviews. 47:46-83 
92. Tsai, Chao-Ming., and C. E. Frasch. 1982. A Sensitive 
Silver stain for Detecting Lipopolysaccharide in 
Polyacrylamide gels. Anal. Biochem. 119:115-119 
93. Van der Ley, P. 1988. Three copies of a sihgle 
protein II-encoding sequence in the genome of Neisseria 
gonorrhoeae JS3: evidence for gene conversion and gene 
duplication. Molecular Microbiology. 2(6):797-806 
94. Veale, D. R., C. W. Penn, and H. Smith. 1981. Factors 
Affecting the Induction of Phenotypically Determined 
Serum Resistance of Neisseria gonorrhoeae Grown in 
Media Containing Serum or its Diffusible Components. 
J. Gen. Microbiol. 122:235-245 
95. Zak, K., J. L. Diaz, D. Jackson, and J. E. Heckels. 
1984. Antigenic Variation During infection with 
Neisseria gonorrhoea: Detection of Antibodies to 
Surface Proteins in Sera of Patients with Gonorrhoea. 
J. Infect Dis. 149:166-173 
96. Zieg, J., M. Silverman, M. Hilmen, and M. Simon. 1977. 
85 
Recombination Switch for Gene Expression. Science 
196:170-172 
86 
